Björk J - Search Results

1

Linomide suppresses both Th1 and Th2 cytokines in experimental autoimmune myasthenia gravis.

Zhang GX, Yu LY, Shi FD, Xiao BG, Björk J, Hedlund G, Link H. Zhang GX, et al. Among authors: bjork j. J Neuroimmunol. 1997 Mar;73(1-2):175-82. doi: 10.1016/s0165-5728(96)00197-x. J Neuroimmunol. 1997. PMID: 9058774

2

Sulfasalazine aggravates experimental autoimmune encephalomyelitis and causes an increase in the number of autoreactive T cells.

Correale J, Olsson T, Björk J, Smedegård G, Höjeberg B, Link H. Correale J, et al. Among authors: bjork j. J Neuroimmunol. 1991 Nov;34(2-3):109-20. doi: 10.1016/0165-5728(91)90120-v. J Neuroimmunol. 1991. PMID: 1680877

3

Paradoxical effects of LS-2616 (Linomide) treatment in the type II collagen arthritis model in mice.

Björk J, Kleinau S. Björk J, et al. Agents Actions. 1989 Jun;27(3-4):319-21. doi: 10.1007/BF01972810. Agents Actions. 1989. PMID: 2801316

4

Linomide suppresses acute experimental autoimmune encephalomyelitis in Lewis rats by counter-acting the imbalance of pro-inflammatory versus anti-inflammatory cytokines.

Diab A, Michael L, Wahren B, Deng GM, Björk J, Hedlund G, Zhu J. Diab A, et al. Among authors: bjork j. J Neuroimmunol. 1998 May 15;85(2):146-54. doi: 10.1016/s0165-5728(98)00023-x. J Neuroimmunol. 1998. PMID: 9630163

5

Cytokine profiles of experimental autoimmune myasthenia gravis after treatment by the synthetic immunomodulator linomide.

Zhang GX, Yu LY, Shi FD, Xiao BG, Björk J, Hedlund G, Link H. Zhang GX, et al. Among authors: bjork j. Ann N Y Acad Sci. 1998 May 13;841:580-3. doi: 10.1111/j.1749-6632.1998.tb10988.x. Ann N Y Acad Sci. 1998. PMID: 9668300 No abstract available.

6

Linomide suppresses chronic-relapsing experimental autoimmune encephalomyelitis in DA rats.

Zhu J, Diab A, Mustafa M, Levi M, Wahren B, Björk J, Hedlund G. Zhu J, et al. Among authors: bjork j. J Neurol Sci. 1998 Oct 8;160(2):113-20. doi: 10.1016/s0022-510x(98)00244-5. J Neurol Sci. 1998. PMID: 9849793

7

The inhibitory effect in experimental autoimmune encephalomyelitis by the immunomodulatory drug Linomide (PNU-212616) is not mediated via release of endogenous glucocorticoids.

Pekarski O, Björk J, Hedlund G, Andersson G. Pekarski O, et al. Among authors: bjork j. Autoimmunity. 1998;28(4):235-41. doi: 10.3109/08916939808995371. Autoimmunity. 1998. PMID: 9892505 Free article.

8

Linomide suppresses experimental autoimmune neuritis in Lewis rats by inhibiting myelin antigen-reactive T and B cell responses.

Zhu J, Bai XF, Hedlund G, Björk J, Bakhiet M, Van Der Meide PH, Link H. Zhu J, et al. Among authors: bjork j. Clin Exp Immunol. 1999 Jan;115(1):56-63. doi: 10.1046/j.1365-2249.1999.00768.x. Clin Exp Immunol. 1999. PMID: 9933420 Free PMC article.

9

Linomide, a new immunomodulatory drug, shows different effects on homologous versus heterologous collagen-induced arthritis in rats.

Kleinau S, Larsson P, Björk J, Holmdahl R, Klareskog L. Kleinau S, et al. Among authors: bjork j. Clin Exp Immunol. 1989 Oct;78(1):138-42. Clin Exp Immunol. 1989. PMID: 2805418 Free PMC article.

10

Serum hyaluronate levels reflect disease activity in experimental arthritis models.

Smedegård G, Björk J, Kleinau S, Tengblad A. Smedegård G, et al. Among authors: bjork j. Agents Actions. 1989 Jun;27(3-4):356-8. doi: 10.1007/BF01972821. Agents Actions. 1989. PMID: 2508444

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

721 results

Search Page

Filters